Study guide
5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion
AMCB Certified Nurse-Midwife CNM
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care
1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral
2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts
2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy
3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy
3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy
4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss
4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care
5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance
5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion
6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation
6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy
7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair
7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture
8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation
8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications
9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage
9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation
10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health
10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis
11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination
11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes
12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days
12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days
13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization
13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening
14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation
14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral
15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders
15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome
16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause
16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis
17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions
17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking
18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity
18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care
5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion
Key Takeaways Explain This Topic AI
Fetal scalp stimulation that elicits an acceleration of 15 bpm for 15 seconds reliably predicts a scalp pH of 7.20 or higher, and must never be performed during an active deceleration.
Routine prophylactic maternal oxygen is no longer recommended for Category I or uncomplicated tracings; it is reserved for maternal hypoxemia or refractory Category II and III patterns.
A fetal spiral electrode is contraindicated with maternal HIV, hepatitis B or C, active genital herpes, suspected fetal thrombocytopenia or bleeding disorder, placenta previa, and face presentation.
Amnioinfusion is indicated for recurrent variable decelerations from cord compression, using a 250 to 500 mL bolus over 20 to 30 minutes then 100 to 180 mL per hour, with strict input and output tracking.
Amnioinfusion is not recommended as routine prophylaxis for meconium-stained fluid, because trials showed no reduction in meconium aspiration syndrome or perinatal death.
Last updated: September 2026
Intrauterine Resuscitation Bundle & Clinical Interventions
When faced with a Category II indeterminate or Category III abnormal tracing, the CNM immediately executes the evidence-based intrauterine resuscitation algorithm:
Maternal Repositioning: Turn the patient to the full left or right lateral decubitus position . This relieves aortocaval compression by the gravid uterus, improves maternal venous return and stroke volume, and optimizes uterine arterial perfusion. If cord compression is suspected, try hands-and-knees positioning.
Discontinue Uterotonic Agents: Immediately stop oxytocin infusions or remove dinoprostone vaginal inserts to eliminate myometrial hyperstimulation and restore intervillous blood flow.
Intravenous Fluid Bolus: Rapidly infuse 500 to 1,000 mL of Lactated Ringer's solution. Intravascular volume expansion elevates maternal cardiac output and increases placental perfusion pressure.
Correct Maternal Hypotension: If hypotension develops following neuraxial analgesia, administer vasopressors per protocol ( ephedrine 5–10 mg IV or phenylephrine 50–100 mcg IV ) alongside fluid boluses.
Uterine Tocolysis for Tachysystole: If uterine tachysystole (>5 contractions in 10 minutes averaged over 30 minutes) occurs with FHR decelerations and fails to resolve after stopping oxytocin, administer terbutaline 0.25 mg subcutaneously . Terbutaline relaxes myometrial smooth muscle within 2 to 3 minutes, halting contractions and restoring placental perfusion.
Supplemental Oxygen Administration: Administer oxygen at 10 L/min via a non-rebreather face mask . Note: Modern guidelines advise against routine prophylactic oxygen for Category I or uncomplicated tracings, as hyperoxia generates reactive oxygen species. Supplemental oxygen is reserved specifically for maternal hypoxemia or refractory Category II/III tracings failing positional and fluid maneuvers.
Amnioinfusion: For recurrent, severe variable decelerations unresponsive to maternal repositioning, infuse warmed isotonic normal saline via an intrauterine pressure catheter (IUPC) (bolus of 250–500 mL over 30 minutes, followed by maintenance infusion of 100–150 mL/hr). Amnioinfusion restores amniotic fluid cushion volume, directly relieving mechanical umbilical cord compression.
Fetal Scalp Stimulation: During periods of baseline with absent or minimal variability without decelerations, perform digital stroking of the fetal scalp for 15 seconds through the open cervix. Eliciting an acceleration of ≥ 15 bpm for ≥ 15 seconds provides an immediate, 99% reliable correlation that the fetal scalp pH is ≥ 7.20 (excluding metabolic acidemia). Caution: Never perform scalp stimulation during an active deceleration.
Internal Monitoring: The Fetal Spiral Electrode
A fetal spiral (scalp) electrode (FSE) screws a small wire into the fetal scalp and records the fetal electrocardiogram directly , producing the most accurate available assessment of rate and, critically, of variability .
Prerequisites: ruptured membranes, cervical dilation of roughly 2–3 cm or more, and a presenting part that is accessible and definitively identified — placing an electrode on a face, fontanelle, or genitalia causes real injury.
Indications: an external tracing that cannot be reliably obtained (maternal habitus, maternal movement, fetal position), or the need to distinguish the maternal heart rate from the fetal heart rate when the external signal is ambiguous.
Contraindications:
Maternal HIV , hepatitis B , or hepatitis C — invasive monitoring breaches the fetal skin barrier and raises vertical transmission risk.
Active genital herpes lesions.
Suspected fetal bleeding disorder or thrombocytopenia (including alloimmune thrombocytopenia).
Placenta previa or unknown placental location, and face presentation.
Known or suspected fetal anomaly at the presenting part.
Complications: scalp laceration and bleeding, scalp abscess, and — rarely — osteomyelitis or cerebrospinal fluid leak.
Amnioinfusion
Amnioinfusion instills warmed isotonic fluid into the amniotic cavity through an IUPC to restore the fluid cushion around the umbilical cord.
Indication: recurrent variable decelerations attributed to cord compression that persist after maternal repositioning. It is also used for oligohydramnios with cord compression.
Important
Amnioinfusion is not recommended as routine prophylaxis for meconium-stained amniotic fluid. Large randomized trials showed no reduction in meconium aspiration syndrome or perinatal death when it was used for that indication alone.
Technique:
Place an IUPC and document baseline resting tone.
Infuse warmed normal saline or lactated Ringer's : a bolus of 250–500 mL over 20–30 minutes , then a maintenance infusion of about 100–180 mL/hour .
Track total volume infused and total returned . Fluid must drain; if output stops, stop the infusion.
Reassess the fetal heart rate pattern, resting tone, and maternal temperature continuously.
Contraindications: a fetal heart rate pattern requiring immediate delivery, clinical intraamniotic infection, polyhydramnios, known uterine anomaly, placenta previa, and any contraindication to IUPC placement.
Complications: uterine overdistension with elevated resting tone, prolonged decelerations during the bolus, cord prolapse, infection, and — rarely — uterine rupture in a scarred uterus.
Internal Monitoring: The Intrauterine Pressure Catheter
The fetal spiral electrode answers "what is the fetal heart doing?" The intrauterine pressure catheter (IUPC) answers the separate question "how much work is the uterus doing?" — and the two are placed for different reasons.
Prerequisites are the same as for the spiral electrode: ruptured membranes , adequate cervical dilation, and a presenting part that has been definitively identified.
Indications: assessment of labor adequacy when progress has arrested and the external tocodynamometer cannot quantify contraction strength (most often with maternal obesity), titration of oxytocin against measured rather than inferred uterine activity, and delivery of an amnioinfusion.
Contraindications: placenta previa or unexplained bleeding, active genital infection, and any situation in which immediate delivery is indicated.
Complications: placental abruption or vessel perforation on insertion, infection, and — rarely — uterine perforation. An IUPC is also the only route by which quantified uterine work (Montevideo units, covered with uterine activity assessment) can be obtained.
Escalation, Documentation & Communication
A resuscitation bundle that works clinically still fails the patient if it is not communicated. The intrapartum standard of care has two parts, and the second is tested as often as the first:
Document the tracing, not a conclusion. Record baseline rate, variability, the presence and type of accelerations and decelerations, and uterine activity — then the NICHD category, then the interventions performed, then the fetal response to those interventions. "Reassuring" is not documentation; a category assignment with its four supporting elements is.
Escalate with a structured handoff. Use a defined format — situation, background, assessment, recommendation — and state explicitly what you are asking for and by when. "I need you at the bedside now" and "I am activating the cesarean team" carry different meanings and should never be left to inference.
Two further principles govern persistent Category II and any Category III tracing:
A Category III tracing requires prompt evaluation and, if it does not resolve with the resuscitation bundle, expeditious delivery. Category III is not a waiting state.
Persistent Category II demands an explicit plan with a time limit — the intervention chosen, the interval at which the response will be reassessed, and the action that follows if the tracing has not improved. Undocumented, open-ended observation of a Category II tracing is the most common failure mode in intrapartum litigation.